ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

REDX Redx Pharma Plc

12.00
-0.75 (-5.88%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Redx Pharma Plc LSE:REDX London Ordinary Share GB00BSNB6S51 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.75 -5.88% 12.00 11.50 12.00 12.75 11.75 12.75 582,013 16:35:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.2M -33.16M -0.0852 -1.38 45.71M
Redx Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker REDX. The last closing price for Redx Pharma was 12.75p. Over the last year, Redx Pharma shares have traded in a share price range of 4.25p to 36.00p.

Redx Pharma currently has 388,985,916 shares in issue. The market capitalisation of Redx Pharma is £45.71 million. Redx Pharma has a price to earnings ratio (PE ratio) of -1.38.

Redx Pharma Share Discussion Threads

Showing 201 to 222 of 725 messages
Chat Pages: Latest  17  16  15  14  13  12  11  10  9  8  7  6  Older
DateSubjectAuthorDiscuss
25/4/2018
10:18
RNS 20 December 2017 (Final Results to Sept. '17).

Post Period Highlights.

"Exited administration on 2 November 2017 with a cash balance of GB13.9 million".

"....cash runway through to early 2019".

Pp.

piperpeter
25/4/2018
10:11
This will go North sharply again today and for the rest of the week. The medium holders will mutlibag. Dont worry about the dips
ernestsyngen
25/4/2018
10:06
Thanks. well done all!
qs99
25/4/2018
09:58
Obviously, it's the appointment of a new CEO.

No position. Wished I had bought at 4p - :(

be careful and don't get caught on the spike

mirabeau
25/4/2018
09:57
Anticipation of good results IMO and the new CEO would not have come across unless Redx has a superb future. She has clout and backs winners, just look at her past history .

Will be an exciting few months ahead

ernestsyngen
25/4/2018
09:55
Apart from the CEO appointment what is this rise based on please? ta
qs99
25/4/2018
09:53
Target set at 30p by end of week. My come quicker looking at the buys. By the Summer it could well be up into the late 60'70's IMO
gunwharf2
25/4/2018
09:51
I will be taking a keen interest in any late declared large buys today.
ernestsyngen
25/4/2018
09:46
Sure is, I wonder if it will go above 30p this afternoon. People taking positions now. The CEO will want to enter with a BANG and that will be good news of sorts
ernestsyngen
25/4/2018
09:42
This is going for a 2nd climb to 30p
1liam
25/4/2018
09:41
Weak seller out, next stop 175%
cobra786
25/4/2018
09:19
Now I know talk is cheap....but, as a long suffering holder, I am pleased to see phrases used in the RNS such as

'Lisa has been tasked by the Board to lead the re-launch of the Company and to take the steps necessary to build a substantial biotech company'

AND

'I am confident that, as CEO, she is the right person to grow this Company into a very exciting and meaningful entity that has the potential to create both important new medicines for patients and generate significant value for shareholders.'

No guarantees of anything but sounds like there are going to be reasons be cheerful and with someone as well connected as her leading the way, I am much more optimistic for the future.

molatovkid
25/4/2018
09:18
30p on the chart looks do'able. I think more good news is in the pipe line.

Back to the good old days here for investors . Well done all holders and this could be your multibagger of the year!

ernestsyngen
25/4/2018
09:15
Could be today at this rate
cobra786
25/4/2018
09:05
30p easy over Coming days
shirley83
25/4/2018
09:00
ready to explode to 75% +
cobra786
25/4/2018
08:55
Reputation bounce, or perceived validation of RDX's pipeline or closing of short positions, or all or none of the above. All we can say for certain is that the new CEO would not have done extensive due diligence before joining as she was hardly on a sinking ship beforehand.
mdchand
24/4/2018
20:49
Luckily we have some of these near the bottom.
Huge potential ahead .
But , wariness needed .


Best of All

bbr391
24/4/2018
16:34
'The firm is also developing a porcupine drug for conditions such as non-alcoholic steatohepatitis hepatic fibrosis, or NASH for short.

It is the pick of a healthy early-stage programme that includes a tie-up with AstraZeneca, details of which are not currently in the public domain.'

...and the new CEO is from AZ, no?

She must be privy to the 'tie-up'

tinman
24/4/2018
13:02
www.proactiveinvestors.co.uk/companies/news/195633/redx-pharma-recruits-heavy-hitter-from-drugs-major-astrazeneca-195633.html
kamitora
24/4/2018
11:31
She seems well connected and that could be important into the future.

One thing is for sure, if she can turn this thing around and build it up from here that will be a job very well done. It's a massive opportunity but not without its downsides.

molatovkid
24/4/2018
09:34
Would like to see the new appt buying in the market before making a judgement on this, but am intrigued why a seasoned corporate would decide to join this minnow at this time. No doubt a large stock option was part of the package but even so, stock options can only be exercised if they're worth something.
mdchand
Chat Pages: Latest  17  16  15  14  13  12  11  10  9  8  7  6  Older

Your Recent History

Delayed Upgrade Clock